Press Releases

Date	Title
February 4, 2020	Taylor Schreiber to speak at the 2020 PEGS: The Essential Protein Engineering & Cell Therapy Summit, May 4-8, Boston, MA
December 9, 2019	Shattuck Labs Appoints Casi DeYoung as Chief Business Officer
November 5, 2019	Taylor Schreiber to speak at the 2020 CD47/Sirp a Summit – March 18-19th in Boston
October 14, 2019	Shattuck’s ARC platform
October 7, 2019	He Beat Lymphoma at 31, While Pioneering Breakthroughs in Cancer Research
May 6, 2019	Shattuck Labs, Inc. Announces Initiation of Phase 1 Clinical Trial of SL-279252 (PD1/OX40L)
August 10, 2017	Takeda and Shattuck Labs Announce Collaboration to Explore ARC Fusion Proteins in Immuno-Oncology

Investors